The potential role of zuclopenthixol acetate in the management of refractory hyperactive delirium at the end of life.
Tarumi
Yoko
Y
Watanabe
Sharon
S
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003006:Clopenthixol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003693:Delirium / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D013727:Terminal Care / Q000379:methods*
D014150:Antipsychotic Agents; C060342:clopenthixol acetate ester; D003006:Clopenthixol